Only Communists Drive Teslas
By Jeff Siegel
on July 30, 2020
Change happens. And while change can be hard for some folks to accept, it shouldn’t be hard to profit from. Energy and Capital editor Jeff Siegel discusses some upcoming change in the biotech sector and how investors can profit...
Three Stocks to Own as COVID Makes a Comeback
By Jeff Siegel
on July 23, 2020
Today, Energy and Capital editor Jeff Siegel is simply going to share with you three reports that focus on a handful of companies that are already proving to be COVID-resistant...
By Jeff Siegel
on July 16, 2020
Some have called it the most undervalued stock in the biotech space. Energy and Capital editor Jeff Siegel profiles a stock that has developed an anti-aging pill that could change humanity as we know it...
By Jeff Siegel
on July 9, 2020
Energy and Capital editor Jeff Siegel is very bullish right now on a small biotech firm that’s currently conducting clinical trials on a new drug that looks like it could not only completely cure chronic diseases, but even reverse them...
By Jeff Siegel
on July 2, 2020
Doctors from biotech firm Verve Therapeutics have developed a new gene-editing serum that switches off the genes that regulate both LDL cholesterol and triglycerides. Energy and Capital editor Jeff Siegel explains how investors can take advantage...
By Jeff Siegel
on June 25, 2020
Energy and Capital editor discusses what black market libraries, PTSD, the opioid crisis, psychedelic mushrooms and investors all have in common. It may be more than you realize...
